Clinical Efficacy of Ashwagandhadi Granules on Prevention of childhood morbidityChildhood Morbidity
Phase 2
- Registration Number
- CTRI/2022/10/046570
- Lead Sponsor
- Banaras Hindu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children not suffering from acute / chronic or life threatening disorders i.e. Healthy
Children.
Properly Immunised children with routine vaccination (NIP).
Exclusion Criteria
Children age below 1 year and more than 5 years. Children infected with COVID 19
Any severe systemic illness
Congenital malformations.
Herediatory disease
Inborn error of metabolism
Chronic illness.
Not accepting orally
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptomatic scale <br/ ><br>CBC <br/ ><br>ESR <br/ ><br>Throat swab <br/ ><br>X ray Chest PA view <br/ ><br>Covid RTPCRTimepoint: one month
- Secondary Outcome Measures
Name Time Method Cough <br/ ><br>Dyspnoea <br/ ><br>Chest pain <br/ ><br>Nature of Phlegm <br/ ><br>Nasal congestion <br/ ><br>Rhinorrhea <br/ ><br>Wheezing/Rhonchi <br/ ><br>Fever <br/ ><br>Headache <br/ ><br>Sore throat <br/ ><br>Fatigue <br/ ><br>Abdominal Pain <br/ ><br>Diarrhea <br/ ><br>Vomiting <br/ ><br>AppepiteTimepoint: 3 follow up will be done at 10th day, 20th day and 30th day.